Hi Investormate
Cheers for that article. SHE have performed very well and it's no fluke. It's the quality projects and an ethical shareholder focussed board of directors that are behind the substantial re-ratings that have occurred. And IMO, will continue to occur as the company begins to set up earning potentials with the manufacture and world wide distribution of the Protean WEC and sales income from the potentially large high grade U308/Vanadium joint venture in Korea.
Regards,
Chilloutman
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.106M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 131450 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2355481 | 4 |
View Market Depth
| Last trade - 09.59am 18/07/2025 (20 minute delay) ? |
| SHE (ASX) Chart |
Day chart unavailable